Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.naturalcapsules.com | |
Market Cap | 322.96 Cr. | |
Enterprise Value(EV) | 412.57 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 19.72 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 17.51 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 131.89 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 2.62 | Calculated using Price: 345.45 |
Dividend Yield | 0.29 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.93 Cr. | 9,349,050 Shares |
FaceValue | 10 | |
About Natural Capsules Ltd. | ||
Natural Capsules is a public limited company established in the year 1993.The company is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form. |
1 Day |
|
-0.35% |
1 Week |
|
-1.37% |
1 Month |
|
-24.28% |
3 Month |
|
-19.45% |
6 Month |
|
-33.97% |
1 Year |
|
-20.98% |
2 Year |
|
+171.00% |
5 Year |
|
+322.57% |
10 Year |
|
+1157.55% |
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.05 | 3.50 | 1.54 | 11.74 | 19.18 | |
Return on Capital Employed (%) | 3.71 | 4.51 | 3.71 | 14.52 | 20.92 | |
Return on Assets (%) | 1.56 | 2.66 | 1.16 | 8.05 | 10.65 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 54 | 55 | 56 | 62 | 83 | 123 | |
Non Curr. Liab. | 2 | 1 | 1 | 2 | 35 | 74 | |
Curr. Liab. | 15 | 16 | 18 | 33 | 46 | 67 | |
Minority Int. | |||||||
Equity & Liab. | 71 | 73 | 75 | 97 | 164 | 289 | |
Non Curr. Assets | 29 | 35 | 37 | 47 | 89 | 187 | |
Curr. Assets | 42 | 38 | 38 | 50 | 76 | 101 | |
Misc. Exp. not W/O | |||||||
Total Assets | 71 | 73 | 75 | 97 | 164 | 289 |
Particulars | 6 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 55 | 60 | 62 | 80 | 135 | 172 | |
Other Income | 1 | 1 | 1 | 1 | 2 | 1 | |
Total Income | 56 | 61 | 63 | 80 | 137 | 173 | |
Total Expenditure | -49 | -55 | -56 | -68 | -111 | -137 | |
PBIDT | 6 | 6 | 6 | 12 | 27 | 36 | |
Interest | 0 | -1 | -1 | -1 | -2 | -3 | |
Depreciation | -4 | -3 | -4 | -4 | -5 | -7 | |
Taxation | -1 | 0 | -1 | -2 | -5 | -7 | |
Exceptional Items | 0 | 2 | |||||
PAT | 1 | 2 | 1 | 7 | 14 | 18 | |
Minority Interest | |||||||
Share Associate | |||||||
Other Related Items | 0 | 0 | |||||
Consolidated Net Profit | 1 | 2 | 1 | 7 | 14 | 18 | |
Adjusted EPS | 1 | 3 | 1 | 9 | 20 | 23 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 5 | 2 | 7 | 6 | 1 | |
Cash Fr. Inv. | -1 | -7 | -6 | -9 | -46 | |
Cash Fr. Finan. | -4 | 4 | -1 | 3 | 46 | |
Net Change | 0 | -1 | 0 | 0 | 1 | |
Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 1 |
Fri, 09 Jun 2023
Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 We wish to inform you that M/S SOMERSET INDUS HEALTHCARE FUND II have invested Rs. 31 38 48 225/- (Rupees Thirty One Crore Thirty Eight Lakhs Forty Eight Thousand Two Hundred Twenty Five Only) in Subsidiary Company M/S Natural Biogenex Private Limited at a pre money valuation of Rs. 250 crores. The Board of M/S Natural Biogenex Private Limited (Subsidiary) on their meeting held today i.e. 09.06.2023 have considered and approved Allotment of 27 89 762 Cumulative Compulsorily Convertible Preference Shares (CCPS) of Rs. 70/- each at Rs. 112.50 per shares (including premium of Rs. 42.50/-) to M/S SOMERSET INDUS HEALTHCARE FUND II. |
Fri, 09 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication With reference to the captioned subject We hereby inform that Notice to the shareholders for transfer of shares to Investors Education & Protection Fund (IEPF) has been published in Business Line-An English daily & Sanjevani- a Kannada daily.We enclose herewith the copies of Newspaper for your reference and records. |
Thu, 08 Jun 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of SEBI (Listing obligations & Disclosure Requirements) Regulations 2015 we wish to bring to inform that 2 shareholders have reported to company about loss of their share certificates and requested the Company to issue a duplicate share certificate. The particulars relating to loss of share certificate are attached herewith. |
Fri, 09 Jun 2023 |
|
|
|
|
|